Ginsenoside Rg3 liposomes regulate tumor microenvironment for the treatment of triple negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ginsenoside Rg3 liposomes regulate tumor microenvironment for the treatment of triple negative breast cancer

Published:2023-01-02 Issue:1 Volume:49 Page:139-148
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Miao Linan¹,Ma Hao¹,Dong Tingjun¹,Zhao Chengcheng¹,Gao Tingyu¹,Wu Tianyi¹,Xu Huan¹,Zhang Jing²

Affiliation:

1. Department of Pharmacy, School of Chemistry and Chemical Engineering, Liaoning Normal University, Dalian, People’s Republic of China

2. Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang, People’s Republic of China

Funder

Open Project of Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Chinese Medicine

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2023.2188078

Reference36 articles.

1. Triple-negative breast cancer: a clinical update

2. Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation

3. Fibroblasts in cancer

4. Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling

5. Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly(lactic acid hydroxyacetic acid)-poly(ethylene glycol)-modified ginsenoside Rg3 nanomedicine enhances anti-tumor effect in hepatocellular carcinoma;Drug Development and Industrial Pharmacy;2024-09-11

2. Ginsenosides in cancer: Proliferation, metastasis, and drug resistance;Biomedicine & Pharmacotherapy;2024-08

3. Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer;Molecules;2023-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3